We identified and validated a set of novel druggable non-oncogene vulnerabilities preferentially related to different lung cancer histotypes; dependency on KDM2A is associated with AD and SCLC, dependency on CSNK1A1 is associated with AD, and dependency on LTB4R2 is associated with SCC. This evidence concerns the gene CSNK1A1 and lung carcinoma.